Adage Capital Partners’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-25,000
Closed -$3.62M – 960
2024
Q4
$3.62M Hold
25,000
– – 0.01% 746
2024
Q3
$1.76M Hold
25,000
– – ﹤0.01% 787
2024
Q2
$1.56M Buy
+25,000
New +$1.74M ﹤0.01% 789

Other funds holding ATYR

Adage Capital Partners's ATYR Position: Q1 2025 in Review

Adage Capital Partners sold out of aTyr Pharma (ATYR) in Q1 2025, closing a stake of 25,000 shares — an estimated $3.62M sold.

Adage Capital Partners first reported a position in ATYR in Q2 2024 and held it in 3 quarters. The position peaked at $3.62M in Q4 2024. 85 funds tracked by Wall St. Rank hold ATYR as of Q1 2025.

  • Adage Capital Partners reported no remaining aTyr Pharma position as of Q1 2025 after selling out during the quarter.
  • Adage Capital Partners sold 25,000 aTyr Pharma shares in Q1 2025, an estimated $3.62M.
  • Adage Capital Partners first reported a position in aTyr Pharma in Q2 2024 and held it in 3 quarters.
  • Adage Capital Partners's aTyr Pharma position peaked at $3.62M in Q4 2024.
  • 85 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2025.

Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.